Is Burnham's 'Manchesterism' the fix for health & social care?
Jul 24, 2026 - 49:43
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsA blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatment for primary progressive multiple sclerosis, following a patient petition that highlighted internal disagreements among a...
MS drug controversy, adoption outcomes in Sweden, and the multi-factorial reality of Alzheimer’s is an episode from The BMJ Podcast by The BMJ. A blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatm...
This episode belongs to The BMJ Podcast.
Use the player on this page to stream the episode online.
Published Apr 24, 2026, 38:30 long, audio available.
Continue listening to more episodes from The BMJ Podcast.
Jul 24, 2026 - 49:43
Jul 10, 2026 - 34:42
Jun 26, 2026 - 38:25
Jun 12, 2026 - 36:51
Jun 6, 2026 - 41:02